| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,741 |
9,629 |
$674K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
4,704 |
3,599 |
$540K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,744 |
1,393 |
$316K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
693 |
415 |
$118K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,962 |
1,668 |
$97K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,826 |
1,639 |
$58K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,966 |
1,769 |
$31K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
514 |
400 |
$29K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
3,428 |
1,982 |
$21K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
172 |
120 |
$17K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
231 |
191 |
$16K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
216 |
194 |
$16K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
3,673 |
2,577 |
$13K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
268 |
81 |
$13K |
| 99215 |
Prolong outpt/office vis |
185 |
149 |
$12K |
| 80053 |
Comprehensive metabolic panel |
1,959 |
1,486 |
$11K |
| 84443 |
Thyroid stimulating hormone (TSH) |
946 |
774 |
$9K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
106 |
85 |
$7K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
67 |
54 |
$6K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
77 |
64 |
$5K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
77 |
65 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
589 |
432 |
$4K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
61 |
56 |
$4K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
113 |
37 |
$4K |
| 80061 |
Lipid panel |
427 |
358 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,000 |
705 |
$4K |
| 71046 |
Radiologic examination, chest; 2 views |
46 |
40 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
595 |
486 |
$3K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
37 |
36 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
131 |
110 |
$3K |
| 90686 |
|
959 |
881 |
$3K |
| 71045 |
Radiologic examination, chest; single view |
56 |
38 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
131 |
110 |
$2K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
75 |
43 |
$2K |
| 0002A |
|
58 |
56 |
$2K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
13 |
12 |
$2K |
| 99205 |
Prolong outpt/office vis |
27 |
24 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
4,222 |
3,076 |
$2K |
| 0064A |
|
65 |
65 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
25 |
13 |
$1K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
339 |
229 |
$1K |
| 0001A |
|
33 |
33 |
$1K |
| 0004A |
|
59 |
55 |
$1K |
| 80306 |
|
118 |
76 |
$1K |
| 0072A |
|
55 |
54 |
$1K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
16 |
16 |
$1K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18 |
15 |
$979.65 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
26 |
26 |
$926.20 |
| 0071A |
|
49 |
40 |
$850.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
243 |
143 |
$773.58 |
| 87631 |
|
16 |
15 |
$763.58 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
22 |
17 |
$692.26 |
| 81001 |
|
364 |
286 |
$647.08 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
228 |
152 |
$585.34 |
| 96127 |
|
96 |
92 |
$550.98 |
| 86803 |
|
39 |
39 |
$437.47 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
127 |
109 |
$421.32 |
| 99443 |
|
42 |
22 |
$377.87 |
| 83690 |
|
87 |
69 |
$354.00 |
| 84484 |
|
50 |
41 |
$290.90 |
| 0054A |
|
15 |
14 |
$281.46 |
| 92015 |
Determination of refractive state |
19 |
19 |
$237.69 |
| 90656 |
|
67 |
66 |
$213.07 |
| 87070 |
|
30 |
25 |
$164.48 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
16 |
16 |
$164.15 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
17 |
12 |
$141.09 |
| 90480 |
|
15 |
14 |
$131.32 |
| 87400 |
|
26 |
12 |
$122.78 |
| 86140 |
|
34 |
28 |
$117.19 |
| 87077 |
|
15 |
14 |
$90.80 |
| 85027 |
|
44 |
25 |
$86.14 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
97 |
67 |
$83.53 |
| 83550 |
|
13 |
12 |
$82.28 |
| 87081 |
|
18 |
12 |
$61.32 |
| 83540 |
|
13 |
12 |
$61.06 |
| 81003 |
|
51 |
42 |
$46.45 |
| J7050 |
Infusion, normal saline solution, 250 cc |
24 |
19 |
$41.22 |
| G0008 |
Administration of influenza virus vaccine |
62 |
46 |
$40.55 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
19 |
12 |
$34.50 |
| 85652 |
|
15 |
13 |
$27.68 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
17 |
12 |
$24.97 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
17 |
12 |
$23.65 |
| 90461 |
|
127 |
111 |
$22.77 |
| 91300 |
|
208 |
186 |
$0.84 |
| 91307 |
|
149 |
137 |
$0.60 |
| 91306 |
|
65 |
65 |
$0.30 |
| 91305 |
|
27 |
24 |
$0.10 |
| 90670 |
|
13 |
13 |
$0.00 |
| 90688 |
|
14 |
13 |
$0.00 |